INFLIXIMAB DYYB and MALAISE

2,844 reports of this reaction

2.0% of all INFLIXIMAB DYYB reports

#9 most reported adverse reaction

Overview

MALAISE is the #9 most commonly reported adverse reaction for INFLIXIMAB DYYB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 2,844 FDA adverse event reports linking INFLIXIMAB DYYB to MALAISE. This represents approximately 2.0% of all 142,758 adverse event reports for this drug.

Patients taking INFLIXIMAB DYYB who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE2,844 of 142,758 reports

MALAISE is a less commonly reported adverse event for INFLIXIMAB DYYB, but still significant enough to appear in the safety profile.

Other Side Effects of INFLIXIMAB DYYB

In addition to malaise, the following adverse reactions have been reported for INFLIXIMAB DYYB:

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

0XYGENACETAMINOPHENACETAMINOPHEN 500MGACETAMINOPHEN AND CODEINE PHOSPHATEACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDEACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, ASPIRIN, AND CAFFEINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEACETAMINOPHEN, CAFFEINEACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DIPHENHYDRAMINE HCLACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCLACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

Frequently Asked Questions

Does INFLIXIMAB DYYB cause MALAISE?

MALAISE has been reported as an adverse event in 2,844 FDA reports for INFLIXIMAB DYYB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with INFLIXIMAB DYYB?

MALAISE accounts for approximately 2.0% of all adverse event reports for INFLIXIMAB DYYB, making it a notable side effect.

What should I do if I experience MALAISE while taking INFLIXIMAB DYYB?

If you experience malaise while taking INFLIXIMAB DYYB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

INFLIXIMAB DYYB Full ProfileAll Drugs Causing MALAISEPfizer Laboratories Div Pfizer Inc Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.